SSY - SunLink Health Systems Inc Stock Price, Fair Value and News

0.65USD-0.05 (-7.14%)Market Closed

Market Summary

USD0.65-0.05

Market Closed

-7.14%

SSY Stock Price

View Fullscreen

SSY RSI Chart

SSY Valuation

Market Cap

4.9M

Price/Earnings (Trailing)

-0.75

Price/Sales (Trailing)

0.11

EV/EBITDA

-1.7

Price/Free Cashflow

-1.55

SSY Price/Sales (Trailing)

SSY Profitability

EBT Margin

-8.28%

Return on Equity

-50.81%

Return on Assets

-35.17%

Free Cashflow Yield

-64.39%

SSY Fundamentals

SSY Revenue

Revenue (TTM)

43.3M

Rev. Growth (Yr)

-20.02%

Rev. Growth (Qtr)

-0.53%

SSY Earnings

Earnings (TTM)

-6.6M

Earnings Growth (Yr)

-257.61%

Earnings Growth (Qtr)

-128.79%

Breaking Down SSY Revenue

Last 7 days

1.5%

Last 30 days

-6.7%

Last 90 days

-22.2%

Trailing 12 Months

-33.3%

How does SSY drawdown profile look like?

SSY Financial Health

Current Ratio

2.62

SSY Investor Care

Shares Dilution (1Y)

0.13%

Diluted EPS (TTM)

-0.93

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2023	39.5M	44.3M	45.4M	43.3M
2022	41.8M	41.3M	38.3M	38.5M
2021	41.0M	40.7M	40.8M	41.0M
2020	48.0M	47.8M	46.6M	43.9M
2019	43.3M	45.6M	47.1M	47.7M
2018	49.9M	46.9M	43.9M	42.2M
2017	55.4M	52.9M	53.0M	52.4M
2016	53.3M	64.9M	60.6M	57.9M
2015	76.0M	77.4M	70.1M	62.1M
2014	93.9M	81.8M	78.1M	77.1M
2013	126.2M	104.8M	103.9M	99.6M
2012	128.9M	128.9M	128.5M	127.5M
2011	157.4M	154.4M	147.1M	138.0M
2010	0	166.3M	163.3M	160.4M

Get all data in R, Python etc through our Historical Stock Data APIs

Tracking the Latest Insider Buys and Sells of SunLink Health Systems Inc

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Nov 24, 2023	turner howard e	bought	968	0.968	1,000	-
Oct 19, 2023	ford c michael	back to issuer	-	-	-46,422	-
Oct 19, 2023	burleson gene e	back to issuer	-	-	-81,601	-
Oct 19, 2023	burleson gene e	back to issuer	-	-	-10,000	-
Oct 19, 2023	thornton robert m jr	back to issuer	-	-	-5,000	ceo, chairman & president
Oct 19, 2023	thornton robert m jr	back to issuer	-	-	-554,562	ceo, chairman & president
Oct 19, 2023	stockslager mark j	back to issuer	-	-	-108,051	cfo & principal acctg officer
Oct 19, 2023	baileys steven j	back to issuer	-	-	-50,000	-
Oct 19, 2023	baileys steven j	back to issuer	-	-	-1,600	-

Which funds bought or sold SSY recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
Mar 11, 2024	VANGUARD GROUP INC	unchanged	-	10,904	78,066	-%
Feb 14, 2024	EARNEST PARTNERS LLC	sold off	-100	-1,661	-	-%
Feb 14, 2024	BRIDGEWAY CAPITAL MANAGEMENT, LLC	unchanged	-	30,241	216,504	-%
Feb 14, 2024	SUSQUEHANNA INTERNATIONAL GROUP, LLP	sold off	-100	-52,285	-	-%
Feb 14, 2024	Granite Investment Partners, LLC	unchanged	-	9,679	69,290	-%
Feb 14, 2024	STATE STREET CORP	unchanged	-	5,538	39,652	-%
Feb 13, 2024	RENAISSANCE TECHNOLOGIES LLC	reduced	-2.03	30,000	243,000	-%
Feb 13, 2024	GEODE CAPITAL MANAGEMENT, LLC	unchanged	-	4,180	29,925	-%
Feb 13, 2024	Tower Research Capital LLC (TRC)	reduced	-2.00	167	1,369	-%

Are Funds Buying or Selling SSY?

Are funds buying SSY calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own SSY

No. of Funds

Unveiling SunLink Health Systems Inc's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Nov 13, 2023	thornton robert m jr	8.74%	619,562	SC 13D/A
Jul 24, 2023	thornton robert m jr	8.74%	619,562	SC 13D/A
May 24, 2021	turner howard e	4.76%	331,675	SC 13D/A
Mar 19, 2021	ault global holdings, inc.	3.65%	252,000	SC 13D/A
Mar 08, 2021	mills christopher h b	0%	0	SC 13D/A
Mar 01, 2021	ault global holdings, inc.	9.91%	683,032	SC 13D
Feb 12, 2021	wittenberg investment management, inc.	4.7%	-	SC 13G/A
Feb 11, 2021	wittenberg investment management, inc.	7.7%	-	SC 13G/A
Sep 27, 2019	thornton robert m jr	9.1%	643,343	SC 13D/A

Recent SEC filings of SunLink Health Systems Inc

View All Filings

Date Filed	Form Type	Document
Feb 13, 2024	10-Q	Quarterly Report
Jan 29, 2024	8-K	Current Report

Peers (Alternatives to SunLink Health Systems Inc)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
JNJ	357.8B	85.2B	-3.67%	-8.64%	10.18	4.2	6.46%	95.94%
MRK	321.7B	60.1B	2.46%	9.45%	881.36	5.35	1.40%	-97.49%
PFE	148.3B	46.5B	-3.80%	-34.05%	-106.79	3.19	42.59%	-114.62%
AMGN	146.3B	28.2B	-0.95%	11.90%	21.78	5.19	7.09%	2.52%
GILD	83.6B	27.1B	-7.68%	-22.69%	14.75	3.08	-0.60%	23.36%
TEVA	14.6B	15.8B	-6.26%	55.93%	-25.32	0.92	6.17%	76.47%
MID-CAP
PRGO	4.1B	4.7B	-2.65%	-15.52%	-325.34	0.89	4.58%	90.97%
ALKS	4.1B	1.7B	-11.07%	-16.83%	11.39	2.44	49.61%	324.78%
BHC	3.1B	8.8B	-10.77%	12.83%	-5.27	0.36	7.79%	-163.11%
AMPH	2.0B	644.4M	-6.43%	-0.05%	14.31	3.05	29.14%	50.51%
SMALL-CAP
TLRY	1.4B	743.2M	-20.35%	-21.70%	-4.05	1.92	24.65%	80.36%
TXMD	22.3M	1.3M	-17.90%	-49.19%	-2.17	17.09	-98.14%	-109.18%
ACRX	16.3M	-	-14.29%	38.83%	-0.89	0.22	2882.68%	-138.52%
AGRX	2.5M	19.6M	-32.73%	-94.43%	-0.18	0.13	80.00%	43.08%
ACOR	645.9K	117.6M	-96.48%	-95.45%	0	0.01	-0.79%	-283.60%

SunLink Health Systems Inc News

Latest updates

SunLink Health Systems Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(*) denotes actual numbers (not divided by Thousands)
Income Statement (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Revenue	-0.5%	8,510,000	8,555,000	14,657,000	11,533,000	10,640,000	7,449,000	9,881,000	10,527,000	10,411,000	10,525,000	10,335,000	9,778,000	10,150,000	10,422,000	10,689,000	12,667,000	12,805,000	11,652,000	10,899,000	12,361,000	12,151,000
EBITDA Margin	-288.8%	-0.04	0.02	0.01	0.00	-0.01	-0.07	0.00	0.16	0.17	0.26	0.20	0.08	0.09	0.02	-	-	-	-	-	-	-
Interest Expenses	31.8%	29,000	22,000	74,000	41,000	5,000	-	3,000	-1,000	-3,000	-14,000	-7,000	-7,000	-7,000	-7,000	-5,000	10,000	-4,000	-30,000	-177,500	-63,000	60,000
Income Taxes	50.0%	3,000	2,000	-	-6,000	-1,000	-	107,000	-25,000	23,000	2,000	110,000	-62,000	15,000	-	296,000	-	-	-	144,000	-226,000	-
Earnings Before Taxes	5.2%	-404,000	-426,000	-2,018,000	-733,000	2,276,000	-605,000	-2,210,000	-959,000	-454,000	2,008,000	4,665,000	-535,000	3,161,000	-291,000	-304,000	-46,000	203,000	-143,000	-999,000	-551,000	258,000
EBT Margin	-317.0%	-0.08	-0.02	-0.03	-0.03	-0.04	-0.11	-0.04	0.13	0.14	0.23	0.17	0.05	0.06	-0.01	-	-	-	-	-	-	-
Net Income	-128.8%	-3,075,000	-1,344,000	-1,426,000	-762,000	1,951,000	-1,558,000	-2,365,000	-990,000	-593,000	1,939,000	4,687,000	-531,000	3,074,000	-340,000	-679,000	-158,000	-42,000	-261,000	-2,221,000	1,042,000	305,000
Net Income Margin	-338.5%	-0.15	-0.03	-0.04	-0.06	-0.07	-0.14	-0.05	0.12	0.13	0.22	0.17	0.04	0.04	-0.03	-	-	-	-	-	-	-
Free Cashflow	54.1%	-741,000	-1,613,000	-1,050,500	232,000	19,000	-1,586,000	-390,000	-1,162,000	-616,000	-1,026,000	-1,129,000	-135,000	-185,000	219,000	-	-	-	-	-	-	-

Balance Sheet

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Balance Sheet																					(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Assets	-13.5%	18,787	21,723	23,268	24,430	24,430	26,826	27,943	29,957	29,957	33,368	31,564	28,078	28,522	28,245	27,971	22,274	22,823	22,823	24,419	27,060	25,726
Current Assets	-17.1%	13,710	16,531	12,274	13,304	15,024	15,406	16,815	19,180	20,082	21,414	21,941	19,354	19,530	20,018	19,923	14,141	14,384	17,066	16,658	19,078	13,194
Cash Equivalents	-27.1%	2,055	2,820	4,486	5,382	5,156	4,951	6,794	7,144	8,315	8,933	9,962	11,098	11,241	11,403	11,184	4,003	4,607	7,670	7,742	9,160	3,326
Inventory	-0.6%	1,593	1,602	1,628	1,787	1,812	1,842	1,748	1,919	1,894	1,917	1,890	1,947	1,927	1,965	1,866	2,102	2,056	1,989	2,016	2,003	1,953
Net PPE	1.0%	2,921	2,891	2,717	8,394	8,427	8,482	8,217	7,922	7,382	6,920	6,554	5,656	5,688	5,622	5,324	5,423	5,412	5,189	5,243	5,488	10,003
Current Liabilities	4.7%	5,228	4,993	4,869	4,677	5,633	8,163	7,691	7,493	6,870	7,545	9,665	8,949	9,061	12,088	11,416	6,453	6,440	9,245	8,410	6,040	5,678
Long Term Debt	-	-	-	-	-	-	3.00	14.00	25.00	36.00	44.00	52.00	2,060	1,759	1,948	1,957	98.00	110	115	127	2,739	2,815
LT Debt, Current	-100.0%	-	3.00	14.00	24.00	30.00	41.00	40.00	39.00	38.00	37.00	3,009	1,272	1,582	1,402	1,401	34.00	327	2,772	2,836	319	292
LT Debt, Non Current	-	-	-	-	-	-	3.00	14.00	25.00	36.00	44.00	52.00	2,060	1,759	1,948	1,957	98.00	110	115	127	2,739	2,815
Shareholder's Equity	-19.1%	13,004	16,079	17,417	18,799	19,561	17,610	19,120	21,217	22,207	22,749	20,810	15,946	16,477	13,403	13,743	14,507	14,762	14,810	15,043	17,271	16,233
Retained Earnings	-185.1%	-1,414	1,661	3,005	4,431	5,193	3,242	4,800	7,165	8,155	8,748	6,809	2,121	2,652	-422	-81.00	597	755	797	1,058	3,210	2,168
Additional Paid-In Capital	0%	10,747	10,747	10,746	10,746	10,746	10,746	10,736	10,736	10,736	10,700	10,700	10,704	10,714	10,714	10,713	10,713	10,768	10,773	10,745	10,745	10,749
Accumulated Depreciation	3.4%	9,129	8,827	8,542	16,155	15,749	15,377	15,703	15,324	14,950	14,630	14,326	14,851	14,530	14,235	14,425	14,039	14,855	14,553	14,277	14,666	20,107
Shares Outstanding	0%	7,041	7,041	7,032	7,032	7,032	6,983	6,954	6,942	6,935	6,924	6,924	6,908	6,899	-	-	-	-	-	-	-	-
Float	-	-	-	-	-	3,134	-	-	-	7,947	-	-	-	6,598	-	-	-	4,383	-	-	-	4,884

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Cashflow From Operations	65.4%	-393	-1,137	-421	605	547	-1,271	364	-244	210	-334	167	164	220	814	4,269	143	-348	-95.00	-910	-661	-314
Cashflow From Investing	29.6%	-369	-524	-464	-374	-327	-611	-754	-918	-820	-687	-1,293	-299	-373	-587	-300	-336	-94.00	104	-405	6,554	697
Cashflow From Financing	40.0%	-3.00	-5.00	-11.00	-5.00	-15.00	39.00	40.00	-9.00	-8.00	-8.00	-10.00	-8.00	-9.00	-8.00	3,212	-411	-2,621	-81.00	-103	-59.00	-450
Buy Backs	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	14.00	97.00	6.00	-	-	4.00	-

SSY Income Statement

2023-12-31

Condensed Consolidated Statements of Operations and Comprehensive Earnings (Loss) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2023	Dec. 31, 2022
Net Revenues	$ 8,510	$ 10,640	$ 17,065	$ 18,089
Costs and Expenses:
Salaries, wages and benefits	2,668	2,481	5,285	5,004
Supplies	39	35	73	65
Other operating expenses	784	720	1,690	1,253
Rent and lease expense	92	92	183	184
Depreciation and amortization	318	288	618	557
Operating Profit (loss)	(433)	2,270	(883)	1,653
Other Income (Expense):
Gains on sale of assets	0	1	2	13
Interest income (expense), net	29	5	51	5
Loss from Discontinued Operations before income taxes	(404)	2,276	(830)	1,671
Income Tax Expense (Benefit)	3	(1)	5	(1)
Loss from Continuing Operations	(407)	2,277	(835)	1,672
Loss from Discontinued Operations, net of tax	(2,668)	(326)	(3,584)	(1,279)
Net Earnings (Loss)	(3,075)	1,951	(4,419)	393
Other comprehensive income	0	0	0	0
Comprehensive Earnings (Loss)	$ (3,075)	$ 1,951	$ (4,419)	$ 393
Continuing Operations:
Basic	$ (0.06)	$ 0.32	$ (0.12)	$ 0.24
Diluted	(0.06)	0.32	(0.12)	0.24
Discontinued Operations:
Basic	(0.38)	(0.05)	(0.51)	(0.18)
Diluted	(0.38)	(0.05)	(0.51)	(0.18)
Net Loss:
Basic	(0.44)	0.28	(0.63)	0.06
Diluted	$ (0.44)	$ 0.28	$ (0.63)	$ 0.06
Weighted-Average Common Shares Outstanding:
Basic	7,040	7,031	7,039	7,007
Diluted	7,040	7,033	7,039	7,010
Product [Member]
Costs and Expenses:
Cost of goods sold	$ 4,761	$ 4,518	$ 9,532	$ 8,887
Service [Member]
Costs and Expenses:
Cost of goods sold	$ 281	$ 236	$ 567	$ 486

SSY Balance Sheet

2023-12-31

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2023	Jun. 30, 2023
Current Assets:
Cash and cash equivalents	$ 2,055	$ 4,486
Receivables - net	3,061	2,592
Inventory	1,593	1,628
Current assets held for sale	5,328	1,920
Prepaid expense and other assets	1,673	1,648
Total current assets	13,710	12,274
Property, plant and equipment, at cost	12,050	11,259
Less accumulated depreciation	(9,129)	(8,542)
Property, plant and equipment - net	2,921	2,717
Noncurrent Assets:
Intangible assets	1,180	1,180
Noncurrent assets held for sale	0	5,812
Right of use assets	649	798
Other noncurrent assets	327	487
Total noncurrent assets	2,156	8,277
TOTAL ASSETS	18,787	23,268
Current Liabilities:
Accounts payable	1,420	1,067
Accrued payroll and related taxes	924	1,027
Current liabilities held for sale	1,839	1,326
Current operating lease liabilities	331	334
Other accrued expenses	714	1,115
Total current liabilities	5,228	4,869
Long-Term Liabilities
Noncurrent liability for professional liability risks	105	138
Long-term operating lease liabilities	332	481
Noncurrent liabilities held for sale	0	192
Other noncurrent liabilities	118	171
Total long-term liabilities	555	982
Commitments and Contingencies
Shareholders’ Equity
Preferred Shares, authorized and unissued, 2,000 shares	0	0
Common Shares, without par value: Issued and outstanding, 7,041 shares at December 31, 2023 and 7,032 at June 30, 2023	3,521	3,516
Additional paid-in capital	10,747	10,746
Retained earnings	(1,414)	3,005
Accumulated other comprehensive income	150	150
Total Shareholders’ Equity	13,004	17,417
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY	$ 18,787	$ 23,268

About SunLink Health Systems Inc

SunLink Health Systems, Inc., through its subsidiaries, provides healthcare products and services in the southeastern United States. It operates in two segments, Healthcare Services and Pharmacy. The Healthcare Services segment owns and operates a 49-licensed-bed acute care hospital, which includes a 26-bed geriatric psychiatry unit; four clinics; and a 66-bed extended care and rehabilitation centre. This segment also provides information technology services; and owns unimproved lands. The Pharmacy segment offers institutional pharmacy services consisting of provision of specialty and non-specialty pharmaceutical and biological products, such as nursing homes, assisted living facilities, behavioural and specialty hospitals, hospices, and correctional facilities; non-institutional pharmacy services, including private residences; and durable medical equipment products and services, including the sale and rental of products for institutional clients or to patients in institutional settings and patient-administered home care, as well as retails pharmacy products and services. SunLink Health Systems, Inc. was founded in 1959 and is based in Atlanta, Georgia.

CEO	Mr. Robert M. Thornton Jr.
WEBSITE	sunlinkhealth.com
INDUSTRY	Pharmaceuticals

SunLink Health Systems Inc Frequently Asked Questions

What is the ticker symbol for SunLink Health Systems Inc? What does SSY stand for in stocks?

SSY is the stock ticker symbol of SunLink Health Systems Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of SunLink Health Systems Inc (SSY)?

As of Tue Apr 23 2024, market cap of SunLink Health Systems Inc is 4.93 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of SSY stock?

You can check SSY's fair value in chart for subscribers.

What is the fair value of SSY stock?

You can check SSY's fair value in chart for subscribers. The fair value of SunLink Health Systems Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of SunLink Health Systems Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for SSY so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is SunLink Health Systems Inc a good stock to buy?

The fair value guage provides a quick view whether SSY is over valued or under valued. Whether SunLink Health Systems Inc is cheap or expensive depends on the assumptions which impact SunLink Health Systems Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for SSY.

What is SunLink Health Systems Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Tue Apr 23 2024, SSY's PE ratio (Price to Earnings) is -0.75 and Price to Sales (PS) ratio is 0.11. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. SSY PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on SunLink Health Systems Inc's stock?

In the past 10 years, SunLink Health Systems Inc has provided -0.071 (multiply by 100 for percentage) rate of return.